EXDI - Exactus, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
1.0000
0.0000 (0.00%)
At close: 3:55PM EDT
Stock chart is not supported by your current browser
Previous Close1.0000
Open1.0300
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.0000 - 1.0300
52 Week Range0.0480 - 4.0000
Volume26,666
Avg. Volume17,402
Market Cap34.935M
Beta (3Y Monthly)6.49
PE Ratio (TTM)N/A
EPS (TTM)-0.3690
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire

    Exactus, Inc. Announces Participation in the Investor Summit and the Sidoti & Company Fall 2019 Conference

    DELRAY BEACH, Fla., Sept. 11, 2019 -- Exactus, Inc. (OTCQB:EXDI) (the “Company”), a farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that.

  • GlobeNewswire

    Exactus, Inc. Listed in MERGENT INDUSTRIAL and INTERNATIONAL Manuals and News Reports™

    Exactus, Inc. (EXDI) (the “Company”), a farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that it has been listed in MERGENT INDUSTRIAL and INTERNATIONAL Manuals and News Reports™ and is included in the bound August 2019 Monthly News Reports. Hemp is a legal type of cannabis plant containing less than 0.3% THC (tetrahydrocannabinol), which is the psychoactive component of the cannabis plant.

  • GlobeNewswire

    Exactus Inc. Provides Hemp Farm Update and Will Begin Taking Orders for Triple A Top Flower

    Exactus Inc. (EXDI) (the “Company”), a farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that it is on track to exceed its initial estimates of 20,000 lbs of top flower and will begin taking orders. Emiliano Aloi, President and Chief Executive Officer of Exactus said, “Our farming efforts and our team’s relentless pursuit of quality are beginning to show. The Company will begin harvesting the top flower on September 15th and will continue to harvest through November.

  • GlobeNewswire

    Exactus Inc. Announces CEO Search – Interim Appointments

    Exactus Inc. (EXDI) a healthcare company pursuing opportunities in hemp derived cannabidiol (CBD) products, today announced that Bobby Yampolsky, founder of Ceed2Med, LLC the Company’s largest shareholder will assume the duties of Interim Chairman and Emiliano Aloi, President, will assume the duties of Interim CEO while the Company undertakes an executive search. The Board of Directors expects to make these appointments and will form an Executive Search Committee. Mr. Yampolsky was appointed to the Board of Directors in June and has already been instrumental in creating material value to the company through his extensive business network as a serial entrepreneur who has created multi hundred million dollar enterprises.

  • GlobeNewswire

    Exactus Inc. to Sponsor South Florida PGA Senior PGA Professional Championship and Exhibit at Upcoming BIG Industry Show

    Exactus Inc. (EXDI) a healthcare company pursuing opportunities in hemp derived cannabidiol (CBD) products, today announced it is an official sponsor of The 2019 SFPGA Senior PGA Professional Championship on August 20-21 at Turtle Creek Club and will also exhibit its products at the upcoming BIG Industry Show on August 22-23 at the Miami Beach Convention Center in Miami, Florida. The Company is also pleased to exhibit at the BIG Industry Show, and will be showcasing its products at Booths: 562 (Main Booth) and 470 (Car Showcase and Executive Area).

  • GlobeNewswire

    Exactus, Inc. Reports Second Quarter 2019 Results

    2019 Highlights January 2019 - Entered into the hemp-derived CBD marketJanuary 2019 - Entered into Development and Supply Agreement with Ceed2MedMarch 2019 - Placed a $1.

  • GlobeNewswire

    Exactus Inc. to Report Second Quarter 2019 Financial Results and Host Conference Call

    Exactus Inc. (EXDI) – (the “Company”), a healthcare company pursuing opportunities in hemp derived cannabidiol (CBD) products, today announced that it plans to report its second quarter 2019 financial results after the U.S. market close on Wednesday, August 14, 2019 and will hold an investor conference call on Thursday, August 15. Exactus’ management will hold a conference call on Thursday, August 15, 2019 at 4:30 p.m. Eastern Time to discuss its financial results and provide a business update for the second quarter ended June 30, 2019. The conference call will be broadcast and available for replay on the investor relations section of the Company’s website at https://ir.exactusinc.com.

  • GlobeNewswire

    Exactus Inc. Acquires Green Goddess - Launches CBD Brands and Acquires Manufacturing Capabilities

    Exactus Inc. (EXDI) – (the “Company”), a healthcare company pursuing opportunities in hemp derived cannabidiol (CBD) products, today announced the acquisition of Green Goddess Extracts, a highly regarded Florida contract manufacturer and formulator of hemp and vape products. Green Goddess manufactures and distributes a premium line of high-quality hemp products sold through distributors and online. Green Goddess Extracts was established in 2017 in order to target CBD products to mass markets through distribution channels including convenience stores, vape shops, gas stations, and tobacco retail storefronts.

  • GlobeNewswire

    Exactus Inc. to Showcase Upcoming Product Portfolio at USA CBD Expo 2019

    Exactus will have a 10'x40' booth located at 102-105 on the showroom floor and will also be catering a premium hosted bar on the first day of the event. During the event, attendees will be able to see and sample our latest CBD products, take advantage of special promotions and discounts, participate in product demonstrations and educational sessions of CBD, and learn about the benefits of Cannabinoids and how Exactus can be your one-stop solution for all your CBD needs. In addition, attendees will be able to watch a series of films that show the progression of Exactus farms up to the current state of growth on a 20 ft screen. Emiliano Aloi, the company’s President, said, “This industry is so new that the actual consumer has little idea of what a professionally-operated farm looks like and where their products come from.

  • GlobeNewswire

    Exactus Inc. Announces Appointment of New Chief Financial Officer

    Mr. Puzder will lead the Company's finance strategy and oversee the Company's financial and administrative operations, including finance, accounting, financial reporting, FP&E, tax, treasury, information technology and risk. Philip Young, who has served as the Exactus Interim Chief Financial Officer, will continue in his position as Chief Executive Officer of the Company.

  • GlobeNewswire

    Exactus, Inc. Provides Update On It’s Farming Activities At Exactus One World In Cave Junction, Oregon

    Farming operations are ahead of schedule and the Company is anticipating an initial AAA Top Flower cut of over 20,000 pounds of multiple strains by mid September. Planting operations are scheduled to be complete by July 8th.

  • GlobeNewswire

    Steven A. Schwartz Joins Exactus Board of Directors

    Exactus Inc. (EXDI) – a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, is pleased to announce the appointment of Steven Allen Schwartz to its Board of Directors, effective June 24, 2019. “I am proud to join the Exactus Board and I look forward to working with Phil and the other Directors as the company builds for the future,” states Steven Schwartz. “This is an exciting time for the industry, and I am delighted to help position the company for success,” continues Schwartz.

  • GlobeNewswire

    Exactus, Inc. Announces Appointment of Bobby Yampolsky to its Board of Directors

    Exactus Inc. (EXDI) (the “Company”), a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, is pleased to announce the appointment of Bobby Yampolsky to its Board of Directors, effective June 24, 2019.

  • GlobeNewswire

    Exactus Inc. to Present at the 9th Annual LD Micro Invitational

    Exactus Inc. (EXDI) (the “Company”), a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, today announced that it will be presenting at the 9th Annual LD Micro Invitational on June 4th, 2019 at 10 AM PST / 1PM EST at the Luxe Sunset Bel Air Hotel in Los Angeles, California.  Phil Young, CEO of Exactus, Inc. will be presenting and meeting with investors throughout the day.

  • GlobeNewswire

    Exactus One World, LLC. Digs in for Initial Cultivation of 200 Acres in Southwest Oregon

    Exactus Inc. (EXDI) (the “Company”), is intensifying its efforts to lead the industry in the hemp-derived Cannabidiol (CBD) market with the Company’s initial planting of seedlings in approximately 200 prime acres located in southwest Oregon on its Exactus One World (“EOW”) farms later this month. The Company is pleased to report the arrival of an independent fairness opinion from Scalar, LLC (“Scalar”)* highlighting EOW’s estimated enterprise value between approximately $55 million and $74 million, supporting a robust future of the growing organization.

  • GlobeNewswire

    Exactus Initiates Operations on Two 100-Acre SW Oregon Industrial Hemp Farms

    Exactus Inc. (EXDI) (the “Company”), an emerging company pursuing seed to consumer opportunities in the hemp-derived Cannabidiol (CBD) market, is pleased to announce that it has received an independent fairness opinion from Scalar, LLC (“Scalar”) in connection with the Company’s acquisition of two operating farms located in Southwest Oregon, as reported in the Company’s March 11 press release. Scalar is a nationwide business valuation firm engaged in valuation services for tax, financial reporting, transaction advisory, and litigation consulting, which is regularly engaged in providing transaction advisory valuation services in connection with mergers and acquisitions.

  • GlobeNewswire

    Exactus Applauds Executive Chairman, Jonathan Gilbert on Launch of Impact Biosciences Corp.

    Exactus Inc. (EXDI), a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, applauds its Executive Chairman of the Board, Jonathan Gilbert, on the launch of Impact Biosciences Corp. Jonathan Gilbert, cannabis industry veteran, and founder and former CEO of SOL Global Investments Corp. (CSE:SOL) (9SB.F) (SOLCF), whose wholly owned subsidiary, Scythian Biosciences Inc. (“SBI”), is seeking to list SBI as a new public company on the Canadian Stock Exchange (“CSE”) following a successful capital raise and spinout.

  • SOL Global to Spin Off Cannabinoid Drug Therapy Research and Development Subsidiary
    CNW Group

    SOL Global to Spin Off Cannabinoid Drug Therapy Research and Development Subsidiary

    TORONTO , April 5, 2019 /CNW/ - SOL Global Investments Corp. ("SOL" or the "Company") (SOL.CN) (9SB.F) (SOLCF)  is pleased to announce that it intends to spin off its wholly-owned subsidiary, Scythian Biosciences Inc. ("SBI"), into an independent, publicly-traded company (the "Spin-off"). In connection with the Spin-off, SBI will be renamed "Impact Biosciences Corp" ("Impact") and will continue to pursue a drug development in the United States for the treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination drug candidate, which is being developed under contract with the University of Miami . Impact's mission is to become the first accepted drug regimen for concussive treatment.

  • GlobeNewswire

    Exactus Acquires Hemp Healthy® Online Consumer and Healthcare Practitioner Brand with Full Traceability

    Exactus Inc. (OTCQB:EXDI / OTCQB:EXDID), a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products announced today it has agreed to acquire Hemp Healthy®, including www.buyhempcbd.com, where consumers can purchase a wide range of tinctures, topical lotions, creams and gel caps.

  • GlobeNewswire

    Exactus Applauds CVS’s Decision to Sell CBD Products

    Exactus Inc. (OTCQB:EXDI / OTCQB:EXDID), a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) products applauds CVS’s decision announced yesterday to begin selling CBD (cannabidiol) products in select stores throughout the country. Exactus believes that the best way for patients and their physicians to feel confident in their choice of CBD products is to purchase them from a trusted name with a proven track record.  There are many choices in the marketplace for CBD products, and it can be confusing for most consumers that are new to using CBD. Philip J Young, CEO, stated, “Our driving mission and philosophy at Exactus is to farm, process and manufacture quality products.  With the quality built into every product and tested to confirm that the potency, purity, and content that is on the label is indeed, exactly what is in the product.  We are happy to see a national icon such as CVS make a statement and begin selling CBD.

  • GlobeNewswire

    Exactus Appoints Emiliano Aloi as President

    OTCQB:EXDID), a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) products, announced it has appointed Emiliano Aloi as President. Philip J. Young, CEO of Exactus, stated: “We are excited to welcome Mr. Aloi as our President. A third-generation family farmer, Mr. Aloi is a pioneer in the space, and has been involved successfully in dozens of agroindustrial projects around the world over his career.

  • GlobeNewswire

    CORRECTION - Exactus Announces Agricultural Diversification with Entry Into 200 Acre Farming Project for 2019 Grow Season – Promotion of Emiliano Aloi as President

    GLEN ALLEN, Va., March 11, 2019 -- This release corrects and replaces the version issued this morning at 6:30 AM ET. The complete and corrected release follows: Exactus Inc..

  • GlobeNewswire

    Exactus Announces Agricultural Diversification with Entry Into 200 Acre Farming Project for 2019 Grow Season – Promotion of Emiliano Aloi as President

    GLEN ALLEN, Va., March 11, 2019 -- Exactus Inc. (OTCQB:EXDID), a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) products, announced it has.

  • GlobeNewswire

    Exactus Announces Stock Split

    Exactus Inc. (EXDI), a healthcare company pursuing opportunities in Hemp derived, Cannabidiol (CBD) products and point of care diagnostics, announced a reverse stock split of its shares of common stock at a ratio of 1-for-8. The purpose of the reverse stock split is to initiate the process of positioning the company for a future listing application to a national exchange. The reverse split will occur at the market open Monday, March 11, 2019, when Exactus Inc. common stock will begin trading on a split-adjusted basis.

  • GlobeNewswire

    Exactus Announces Retirement of Remaining Convertible Notes

    Exactus Inc. (EXDI), a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, today announced that it has retired the last of its outstanding convertible notes. Each note was exchanged for shares of a new series of preferred stock designated as Series A Convertible Preferred Stock. As a result, the Company's convertible notes, which were convertible at variable prices reflecting a predetermined discount to market prices, have been retired and the Company has eliminated this form of indebtedness.